SCHEMBL845697

SCHEMBL845697

Cc1cccnc1C(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3ncccc3C)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 1/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CYP1A2 P05177 1/20 0.43
PABPC1 P11940 1/20 0.43
TSHR P16473 1/20 0.43
MAPT P10636 2/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
RHOC P08134 1/20 0.42
RHOA P61586 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845442 0.89 CYP2C9 (0.43) ALDH1A1CYP2C9CYP2C19KMT2AMEN1
SCHEMBL844980 0.86 ALDH1A1 (0.45) ALDH1A1CYP2C9CYP2C19KMT2AMEN1
SCHEMBL845841 0.85 TRPV1 (0.45) ALDH1A1CYP2C9CYP2C19PABPC1MAPK1
SCHEMBL13272509 0.85 TRPV1 (0.45) ALDH1A1CYP2C9CYP2C19PABPC1MAPK1
SCHEMBL845640 0.84 ALDH1A1 (0.49) ALDH1A1KMT2AMEN1NPSR1TSHR
SCHEMBL845330 0.84 GAA (0.47) ALDH1A1CYP2C9CYP2C19PABPC1TSHR
SCHEMBL845008 0.84 ALDH1A1 (0.54) ALDH1A1CYP2C9CYP2C19KMT2AMEN1
SCHEMBL845651 0.84 CYP2C9 (0.43) ALDH1A1CYP2C9CYP2C19NPSR1PABPC1
SCHEMBL845433 0.83 PABPC1 (0.42) ALDH1A1CYP2C9CYP2C19KMT2AMEN1
SCHEMBL10119343 0.83 ALDH1A1 (0.44) ALDH1A1CYP2C9CYP2C19KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed